NEW YORK, N.Y.—May 25, 2007
New York’s Hospital for Special Surgery celebrates its 24th annual tribute dinner at the World Financial Center Winter Garden. This event is an opportunity to celebrate advances in the field of musculoskeletal treatment and research and to honor individuals who have embraced the spirit of the hospital and supported its mission.
At this event, Richard S. Fuld, Jr., chairman and CEO of Lehman Brothers, will receive a special honor and renowned hip surgeon Eduardo A. Salvati, M.D., will receive a lifetime achievement award for his contributions to the hospital and the field of orthopedic surgery. His work has encompassed basic, applied, clinical and biomechanical research to refine the complex aspects of total hip replacement. Dr. Salvati has been a driving force at Hospital for Special Surgery for 35 years, dedicating his professional career to the care of thousands of patients and to the education and surgical training of residents and fellows.
The dinner will be hosted by Tony and Emmy Award-winning actress, Bebe Neuwirth.
|When:||Thursday, June 7, 2007
6:30 p.m. – 9 p.m.
Cocktail reception begins at 6:30 p.m.
Dinner begins at 7:30 p.m.
|Where:||The World Financial Center Winter Garden|
|Who:||The following individuals have special roles for the evening’s event:
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.